RIPR-PD-1 | m-entrepreneurship.com

Product Name :
RIPR-PD-1

Search keywords :
LY5

drugId :
null

Target Vo:
Leukocyte common antigen

Target Vo Short Name :
L-CA

Moa_Name:
Anti-CD45

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Stanford University

Active Company_Name :
Stanford University

Active Indication_Name:
Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Leronlimab supplier
Ublituximab custom synthesis
Mitofusin 2 Antibody: Mitofusin 2 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 86 kDa, targeting to Mitofusin 2. It can be used for WB,IHC-P,ELISA assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts